Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality
暂无分享,去创建一个
L. Dugan | S. Ali | M. A. Badawy | Basma Yasseen | Engy A. Abdel‐Rahman | Aya A. Elkhodiry | Asmaa M Shedra | Rehab M. Hamdy | Diaa Al-Raawi | M. Hammad | N. Elsharkawy | Ahmed Al-Halfawy | Alaa Elhadad | A. Hatem | S. Abouelnaga | Mona F Zidan | Azza G. Kamel | Riem M. El-Messiery | Hajar El-sayed | Mohamed El Ansary | Rehab M Hamdy
[1] C. Wiedermann. Hypoalbuminemia as Surrogate and Culprit of Infections , 2021, International journal of molecular sciences.
[2] E. Zaky,et al. Autism spectrum disorder (ASD)-associated mitochondrial deficits are revealed in children’s platelets but unimproved by hyperbaric oxygen therapy , 2021, Free radical research.
[3] R. Ohgami,et al. A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity , 2020, International journal of laboratory hematology.
[4] M. Hémadi,et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.
[5] F. Cipollone,et al. IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ? , 2020, Antioxidants & redox signaling.
[6] J. Rotter,et al. Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis , 2020, Journal of medical virology.
[7] Jiaofeng Huang,et al. Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity , 2020, Journal of medical virology.
[8] T. Velavan,et al. Mild versus severe COVID-19: Laboratory markers , 2020, International Journal of Infectious Diseases.
[9] Guiqing He,et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China , 2020, Clinica Chimica Acta.
[10] Jian-Ping Liu,et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.
[11] B. Nordestgaard,et al. Plasma Albumin and Incident Cardiovascular Disease , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[12] M. Gelos,et al. Fatty Acid Binding to Human Serum Albumin in Blood Serum Characterized by EPR Spectroscopy , 2019, ChemistryOpen.
[13] G. Corazza,et al. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis , 2019, Hepatology communications.
[14] A. Meissner,et al. T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated Chemotaxis , 2019, International journal of molecular sciences.
[15] M. Ikura,et al. Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis , 2018, Nature Communications.
[16] A. Stewart,et al. Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding , 2018, Prostaglandins, leukotrienes, and essential fatty acids.
[17] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[18] S. Hallström,et al. Anticoagulant action of low, physiologic, and high albumin levels in whole blood , 2017, PloS one.
[19] N. Yamaotsu,et al. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin , 2017, PloS one.
[20] S. Ali,et al. Physiological and pathophysiological reactive oxygen species as probed by EPR spectroscopy: the underutilized research window on muscle ageing , 2016, The Journal of physiology.
[21] Douglas G. Altman,et al. Adequate sample size for developing prediction models is not simply related to events per variable , 2016, Journal of clinical epidemiology.
[22] David G Levitt,et al. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements , 2016, International journal of general medicine.
[23] P. Ascenzi,et al. Heme-based catalytic properties of human serum albumin , 2015, Cell Death Discovery.
[24] Philbert Lee,et al. Review: modifications of human serum albumin and their binding effect. , 2015, Current pharmaceutical design.
[25] M. Mojović,et al. Binding of doxyl stearic spin labels to human serum albumin: an EPR study. , 2014, The journal of physical chemistry. B.
[26] X. Salvatella,et al. Human serum albumin, systemic inflammation, and cirrhosis. , 2014, Journal of hepatology.
[27] W. Bal,et al. Binding of transition metal ions to albumin: sites, affinities and rates. , 2013, Biochimica et biophysica acta.
[28] T. Amisaki,et al. Fatty acid binding to serum albumin: molecular simulation approaches. , 2013, Biochimica et biophysica acta.
[29] U. Çakatay,et al. Human serum albumin and its relation with oxidative stress. , 2013, Clinical laboratory.
[30] Mehmet Kocak,et al. A Simulation-Based Evaluation of the Asymptotic Power Formulas for Cox Models in Small Sample Cases , 2012, The American statistician.
[31] V. Trezza,et al. Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.
[32] Thomas Agoritsas,et al. Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. , 2011, Journal of clinical epidemiology.
[33] A. Miyanohara,et al. Loss of Caveolin-1 Accelerates Neurodegeneration and Aging , 2010, PloS one.
[34] H. Spiess,et al. The distribution of fatty acids reveals the functional structure of human serum albumin. , 2010, Angewandte Chemie.
[35] K. Schnurr,et al. Fatty acid binding sites of human and bovine albumins: differences observed by spin probe ESR. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[36] E. Bourdon,et al. The antioxidant properties of serum albumin , 2008, FEBS letters.
[37] S. Kazmierczak,et al. Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. , 2006, Clinical chemistry.
[38] S. Curry,et al. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. , 2006, Journal of molecular biology.
[39] P. Ascenzi,et al. Allosteric modulation of drug binding to human serum albumin. , 2006, Mini reviews in medicinal chemistry.
[40] T. Robak,et al. Interaction of doxorubicin and idarubicin with red blood cells from acute myeloid leukaemia patients , 2006, Cell biology international.
[41] Enzo Terreno,et al. The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.
[42] C. Curtain,et al. Fatty-acid spin probe interactions with erythrocyte ghosts and liposomes prepared from erythrocyte ghosts , 1989, The Journal of Membrane Biology.
[43] W. Vanderlaan,et al. Effects of calcium, lanthanum, and temperature on the fluidity of spin-labeled human platelets , 2005, The Journal of Membrane Biology.
[44] P. Sadler,et al. Interdomain zinc site on human albumin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] G. Hersmann,et al. Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. , 2002, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[46] H. Repo,et al. Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFH assay. , 2001, Cytometry.
[47] S. Curry,et al. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.
[48] P. Brick,et al. Fatty acid binding to human serum albumin: new insights from crystallographic studies. , 1999, Biochimica et biophysica acta.
[49] G. Zocchi,et al. Osmotic pressure contribution of albumin to colloidal interactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] H. Powers,et al. Iron-binding antioxidant potential of plasma albumin. , 1997, Clinical science.
[51] B. Honoré,et al. Influence of Fatty Acids on the Binding of Warfarin and Phenprocoumon to Human Serum Albumin with Relation to Anticoagulant Therapy , 1996, The Journal of pharmacy and pharmacology.
[52] M. Cha,et al. Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. , 1996, Biochemical and biophysical research communications.
[53] ScienceDirect. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. , 1996 .
[54] C. Cross,et al. Oxidants, antioxidants, and respiratory tract lining fluids. , 1994, Environmental health perspectives.
[55] J. Doweiko,et al. Reviews: The Role of Albumin in Human Physiology and Pathophysiology, Part III: Albumin and Disease States , 1991 .
[56] J P Doweiko,et al. The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. , 1991, JPEN. Journal of parenteral and enteral nutrition.
[57] J. Freed,et al. ESR studies of stearic acid binding to bovine serum albumin. , 1990, Biochimica et biophysica acta.
[58] M. Shopova,et al. Characterization of spin-labelled fatty acids and hematoporphyrin binding sites interactions in serum albumin. , 1990, Biochimica et biophysica acta.
[59] B. Halliwell,et al. Albumin--an important extracellular antioxidant? , 1988, Biochemical pharmacology.
[60] C. Polnaszek,et al. Spin labels in membranes. Problems in practice. , 1978, Biochimica et biophysica acta.
[61] D. Eatough,et al. The binding isotherms for the interaction of 5-doxyl stearic acid with bovine and human albumin. , 1978, Journal of lipid research.
[62] A. Keith,et al. Spin labels in membranes. , 1972, Chemistry and physics of lipids.
[63] THE JOURNAL OF PHYSICAL CHEMISTRY B , 2022 .